-
0.4% Trypan Blue Solution: Practical Use
2026-09-26
0.4% Trypan Blue Solution provides a membrane-integrity readout for distinguishing unstained cells from blue-stained dead or damaged cells during research cell counting and cell viability measurement. Use it for cultured-cell workflows and as a cytotoxicity assay reagent where appropriate, not for clinical diagnosis or to distinguish apoptosis from necrosis.
-
Angiotensin (1-7): Research Workflows & Assays
2026-09-26
Use Angiotensin (1-7) to investigate Mas receptor biology, renal and inflammatory models, and a newly reported spike–AXL binding phenotype. This guide distinguishes published benchmarks from suggested assay conditions so researchers can design reproducible experiments without mistaking biochemical binding for evidence of viral infection.
-
Merimepodib: Reading IMPDH Dependence in Viral Assays
2026-09-25
Merimepodib (VX-497) offers a way to test whether viral replication depends on host guanine nucleotide synthesis. This article explains how cell-specific metabolism and orthogonal controls can make IMPDH-inhibition experiments more interpretable, using recent PEDV research as a case study.
-
Lyso-Tracker Red: Reading Lysosomal Stress in RCC
2026-09-25
Lyso-Tracker Red can reveal how lysosomal acidity and organization change during renal cancer treatment, but its signal is not a direct readout of membrane rupture. This guide connects live-cell imaging to evidence on SGI-1027 and everolimus, with practical advice for designing and interpreting assays.
-
Ivermectin: Parasitology Research and Evidence Limits
2026-09-24
Ivermectin is a broad-spectrum anti-parasitic with established uses in selected parasitic diseases and topical conditions. This guide summarizes its parasite-directed mechanism, A2813 product specifications, and practical assay limits while making clear that pancreatic cancer research on GSDMC does not establish an oncology role for ivermectin.
-
Spatial Kidney Assembloids Improve Disease Modeling
2026-09-24
Huang and colleagues developed human and mouse kidney progenitor assembloids that organize nephron and collecting-system progenitors into a spatially patterned tissue, improving cellular complexity and functional capacity over conventional kidney organoids. In vivo-grown PKD2-deficient assembloids reproduced features of autosomal dominant polycystic kidney disease and revealed interactions among cyst epithelium, stroma, and macrophages, offering a more structured platform for disease studies.
-
Omeprazole A2845: H+,K+-ATPase Workflow
2026-09-23
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for gastric acid secretion research, antiulcer activity studies, and related assay development. This guide covers solvent selection, assay controls, storage, and troubleshooting; the material is for scientific research only and is not intended for diagnostic, medical, or clinical use.
-
Cyclopamine Workflows for Hedgehog Research
2026-09-22
Cyclopamine provides a practical way to perturb Smoothened-dependent Hedgehog signaling across cancer and developmental models. This guide connects dose-controlled cell assays with comparative genital-tubercle studies, emphasizing controls, readouts, formulation, and troubleshooting.
-
Niclosamide: Designing Mechanism-First Assays
2026-09-22
Niclosamide is a small-molecule STAT3 inhibitor with applications spanning cancer research, apoptosis, and cell-cycle studies. This article presents an evidence-bound assay framework and explains how a molluscicidal study can sharpen experimental interpretation without overstating cross-domain evidence.
-
Sex Differences in Angiotensin II Hypertension in Mice
2026-09-21
Xue, Pamidimukkala, and Hay used telemetry in conscious mice to show that chronic angiotensin II produces substantially greater hypertension in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this difference to sex-hormone-dependent and autonomic mechanisms, providing a rigorous framework for sex-aware cardiovascular research.
-
Sex Differences in Angiotensin II Hypertension
2026-09-21
Xue, Pamidimukkala, and Hay demonstrated that chronic angiotensin II infusion produces substantially greater hypertension in male than female conscious mice, while gonadectomy reverses much of this pattern. Telemetry, baroreflex testing, and ganglionic blockade linked the blood-pressure difference to sex-dependent autonomic and reflex regulation rather than baseline pressure alone.
-
L-Phenylephrine in Sex-Aware α1A Research
2026-09-20
L-Phenylephrine provides a controlled adrenergic α1A receptor agonist challenge for separating acute receptor signaling from chronic angiotensin II hypertension. This guide translates sex-aware telemetry findings into practical cardiovascular, cardiomyocyte, and neural assay decisions.
-
FLT3–TAZ Signaling in Drug-Resistant BP-CML
2026-09-19
Shin et al. reposition FLT3 from an AML-associated kinase to a prognostic marker and therapeutic target in blast-phase chronic myeloid leukemia. Their data connect FLT3 to a JAK–STAT3–TAZ–TEAD–CD36 resistance program and support biomarker-guided combinations with BCR::ABL1-directed therapy.
-
Geneticin, G-418 Sulfate: A Translational Strategy
2026-09-19
Geneticin is more than a routine selection antibiotic: it is a controlled perturbation of eukaryotic translation with implications for cell-line engineering, phenotype interpretation, and antiviral assay design. This thought-leadership perspective connects G418 selection with the metabolic logic of hepatic stellate-cell activation while defining the evidence boundaries required for translational rigor.
-
Gamithromycin PK/PD Workflow for Respiratory Research
2026-09-18
Build respiratory infection assays around Gamithromycin’s lung-site exposure rather than plasma concentration alone. This workflow connects MIC testing, pulmonary epithelial lining fluid pharmacokinetics, and practical troubleshooting for Pasteurella multocida, Haemophilus parasuis, and related pathogens.